December 5, 2007
"Building a Comprehensive Response: Funding for HIV Vaccines, Microbicides and Other New Preventive Options: 2000 to 2006," HIV Vaccine and Microbicides Resource Tracking Working Group: The report provides estimates of investment in HIV vaccine and microbicide research and development from 2000 to 2006. The report also includes estimates of investment in new prevention options -- including male circumcision, suppression of the genital herpes virus HSV-2, cervical barriers and pre-exposure prophylaxis.
The report found that over the seven year period, public and philanthropic funding for HIV vaccine and microbicide research and development almost tripled. In 2006, total global investment in preventive HIV vaccine research and development was about $933 million -- a 23% increase compared with 2005 funding levels. For microbicide research and development during the same year, worldwide investment was about $222 million -- a 35% increase compared with 2005. Between 2000 and 2006, five public-sector funders and two foundations provided $183.6 million for research and development in support of new prevention options, the report found. The report added that financial needs for research and development will "remain substantial in the coming years" ("Building a Comprehensive Response: Funding for HIV Vaccines, Microbicides and Other New Preventive Options: 2000 to 2006," November 2007).
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.